← Evidence map

ArticleJournal of neuro-oncology2012

Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma.

David A Reardon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 22407177